SEC Form 4 · accession 0001652252-16-000134
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giovanni Magni
Officer — EVP, Chief Strategy Officer
Period of report
Nov 4, 2016
Accepted (ET)
Nov 8, 2016 · 1:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Nov 4, 2016 | M | 240 | $0.00 | A | 13,745 | D | |
| Bio-Rad A Common StockF2 | Nov 7, 2016 | S | 91 | $165.62 | D | 13,654 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | $0.00 | Nov 4, 2016 | M | 240 | D | — | — | Bio-Rad A Common Stock | 240 | 0 | D |
Explanation of responses
- F1Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
- F3Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F4The restricted stock units vest in five equal annual installments beginning November 4, 2012.